June 17, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
FDA approves oral Utebzi for complicated UTIs
The FDA has approved oral Utebzi tablets as a treatment for complicated urinary tract infections, including pyelonephritis, in adults with “limited or no alternative oral treatment options,” the agency announced.Utebzi (tebipenem pivoxil, GSK and Spero Therapeutics) is the first oral carbapenem antibiotic approved for complicated UTIs in the United States. It is the second complicated
681 words~3 min read
